Market analysts liked the news, with analysts for Cantor writing that this was a “best-case data update.” ...
CRISPR Therapeutics (CRSP) presented data from the Company’s ongoing Phase 1/2 dose escalation clinical trial evaluating the safety and ...
Recent research published in the journal “Science Bulletin” detailed the creation of a tool called ChCas12b that can ...
Kevin Esvelt, an associate professor at the MIT Media Lab and the inventor of CRISPR-based gene drive, joins Radio Boston.
New genetic medicines for sickle cell disease were hailed as a milestone. Now researchers are working on ways to widen access ...
A new kind of cancer gene therapy can be remotely activated at a specific part of the body. The team developed a version of ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced longer-term data for CASGEVY™ (exagamglogene autotemcel) from global clinical trial ...
The biotech industry has lagged the broader market so far in 2024. The SPDR S&P Biotech ETF, an industry benchmark, is up 9% ...
立陶宛的研究人员展示了一种新的、更通用的基因编辑CRISPR系统的分子结构。 科学家们公布了著名基因编辑工具CRISPR的新版本,它可以暂时“暂停”一个给定的基因,而不是永久地关闭它。
A research group led by Jacob Corn has just discovered that the use of AZD7648 has serious side effects. The study has just ...
The payment scheme will tie gene therapy payments to improvements in health outcomes—and could potentially boost the uptake ...
It's getting harder these days to find great growth stocks trading for less than $100 a share. It almost seems like a higher ...